COVID-19: Limiting the Risks for Eye Care Professionals

References

• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. J Am Med Assoc. 2020;1–9.
   Web of Science ®Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]. 2020:1–13. http://www.ncbi.nlm.nih.gov/pubmed/32109013.
   PubMed Web of Science ®Google Scholar
• https://www.worldometers.info/coronavirus/#countries. Accessed April 7, 2020.
   Google Scholar
• Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm [Internet]. 2020;1–5. http://www.ncbi.nlm.nih.gov/pubmed/32175797.
   Web of Science ®Google Scholar
• Lai THT Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. 2020; (Cdc).
   Google Scholar
• World Health Organization. WHO director-general ’ s remarks at the media briefing on 2019-nCoV on 11 February. 2020 February:1–5. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. Accessed March 24, 2020.
   Google Scholar
• Loon SC, Teoh SCB, Oon LLE, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004;88(7):861–863. doi:10.1136/bjo.2003.035931.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO recommendations to reduce risk of transmission of emerging pathogens from animals to humans in live animal markets. Heal Top [Internet]. 2020. https://www.who.int/health-topics/coronavirus/who-recommendations-to-reduce-risk-of-transmission-of-emerging-pathogens-from-animals-to-humans-in-live-animal-markets. Accessed December 2019.
   Google Scholar
• Sahin AR. 2019 novel coronavirus (COVID-19) outbreak: A review of the current literature. Eurasian J Med Invest [Internet]. 2020;4(1):1–7. https://www.ejmo.org/10.14744/ejmo.2020.12220/.
   Google Scholar
• Kampf G, Todt D, Pfaender S, Steinmann E.Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents J Hosp Infect [Internet]. Mar 1, 2020:104(3);246–251. https://linkinghub.elsevier.com/retrieve/pii/S0195670120300463. Accessed March 28, 2020.
   PubMed Web of Science ®Google Scholar
• Casanova LM, Jeon S, Rutala WA, Weber DJ, Sobsey MD. Effects of air temperature and relative humidity on coronavirus survival on surfaces. Appl Environ Microbiol. 2010;76(9):2712–2717. doi:10.1128/AEM.02291-09.
   PubMed Web of Science ®Google Scholar
• Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir [Internet]. 2020;2600(20):30116. http://dx.doi.org/10.1016/S2213-2600(20)30116-8.
   Google Scholar
• Vaajanen A, Vapaatalo H. Local ocular renin-angiotensin system - a target for glaucoma therapy? Basic Clin Pharmacol Toxicol. October 2011;109(4):217–224. doi:10.1111/j.1742-7843.2011.00729.x. Epub 2011 Jul 28. Review.
   PubMed Web of Science ®Google Scholar
• Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637. doi:10.1002/path.1570.
   PubMed Web of Science ®Google Scholar
• Belser JA, Rota PA, Tumpey M. Ocular tropism of respiratory viruses. Mol. Biol. Rev. 2013;77(1):144–156.
   Google Scholar
• Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. March 10, 2020. doi:10.7326/M20-0504.
   PubMed Web of Science ®Google Scholar
• wei LC, fen LX, fang JZ. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet [Internet]. 2020;395(10224):e39. doi:10.1016/S0140-6736(20)30313-5.
   PubMed Web of Science ®Google Scholar
• Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol [Internet]. 2020;0–3. http://www.ncbi.nlm.nih.gov/pubmed/32100876.
   Web of Science ®Google Scholar
• Zhou Y, Zeng Y, Tong Y, Chen C. Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. medRxiv [Internet]. 2020. 2020.02.11.20021956. https://www.medrxiv.org/content/10.1101/2020.02.11.20021956v1. Accessed March 28, 2020.
   Google Scholar
• Vabret A, Mourez T, Dina J, et al. Human coronavirus NL63, France. Emerg Infect Dis. 2005;11(8):1225–1229. doi:10.3201/eid1108.050110.
   PubMed Web of Science ®Google Scholar
• Xu L, Zhang X, Song W, et al. Conjunctival polymerase chain reaction-tests of 2019 novel coronavirus in patients in Shenyang,China. medRxiv. 2020. 2020.02.23.20024935.
   Google Scholar
• World Health Organization. Infection Prevention and Control of Epidemic- and Pandemic-prone Acute Respiratory Infections in Health Care. Geneva:World Health Organization; 2014. https://apps.who.int/iris/bitstream/handle/10665/112656/9789241507134_eng.pdf?sequence=1.
   Google Scholar
• WHO infection prevention and control guidance for COVID-19. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/infection-prevention-and-control. Accessed March 15, 2020.
   Google Scholar
• Rational use of PPE for COVID-19. https://apps.who.int/iris/bitstream/handle/10665/331498/WHO-2019-nCoV-IPCPPE_use-2020.2-eng.pdf. Accessed March 15, 2020.
   Google Scholar
• Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings. https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html. Accessed March 16, 2020.
   Google Scholar
• Infection Prevention and Control (IPC) for novel coronavirus (COVID-19) Course. https://openwho.org/courses/COVID-19-IPC-EN. Accessed March 20, 2020.
   Google Scholar
• Strategies for optimizing the supply of N95 respirators: COVID-19 | CDC [Internet]. https://www.cdc.gov/coronavirus/2019-ncov/hcp/respirators-strategy/index.html. Accessed March 28, 2020
   Google Scholar
• Hick JL, Barbera JA, Kelen GD. Refining surge capacity: conventional, contingency, and crisis capacity. Disaster Med Public Health Prep. 2009 Jun;3(SUPPL. 1):S59–S67. doi:10.1097/DMP.0b013e31819f1ae2.
   PubMedGoogle Scholar
• Britt JM, Clifton BC, Barnebey HS, Mills RP. Microaerosol formation in noncontact ‘air-puff’ tonometry. Arch Ophthalmol. 1991;109(2):225–228. doi:10.1001/archopht.1991.01080020071046.
   PubMedGoogle Scholar